Tellgen Corporation
300642
Rang in aandelen
#13949
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of... Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Aandeelprijs
$2.59
Marktkapitalisatie
$420.62M
Verandering (1 dag)
-9.56%
Verandering (1 jaar)
-28.57%
Land
CN
Handel Tellgen Corporation (300642)
Categorie
Healthcare
Koersgeschiedenis voor Tellgen Corporation (300642)
Hoogste slotkoers: $2.80 op 2026-10-01
Laagste slotkoers: $3.59 op 2017-04-01
Laagste slotkoers: $3.59 op 2017-04-01
Koersgeschiedenis van Tellgen Corporation van 2017 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -7.04% |
| 2025 | 24.20% |
| 2024 | -14.78% |
| 2023 | -20.19% |
| 2022 | -35.03% |
| 2021 | 2.84% |
| 2020 | 47.58% |
| 2019 | -6.06% |
| 2018 | -34.45% |
| 2017 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $102.65 | -19.77% |
US
|
|
| $96.45 | 0.57% |
IE
|
|
| $307.12 | -20.92% |
US
|
|
| $46.02 | -55.69% |
US
|
|
| $47.05 | -17.88% |
DE
|
